Poland's pharma distribution seeing many changes, with significant consolidation among wholesalers

9 February 2010

In recent years, the pharmaceutical distribution market in Poland has seen many changes. The wholesale distribution segment has experienced consolidation, including combinations between leading players, as well as the privatization of State Treasury outlets. New forms of distribution have also been developed, such as direct/DTP distribution.

According to the latest report by the local research and consulting company PMR, titled 'Distribution on the pharmaceutical market in Poland 2010: Development forecasts for 2010-2012,' during the 2008-2009 period, the pharmaceutical distribution sector in Poland saw further consolidation, both among distributors and among retailers. The most important event in the wholesale distribution segment was the buyout of Prosper by Torfarm, another leading distributor on the Polish market, in April 2009. After the fusion, the two companies together control more than 30% of the market of distribution to pharmacies in Poland.

The takeover of Prosper by Torfarm was one example of a new trend that is becoming visible on the wholesale market in Poland - consolidation among the largest players. Prior to this, the takeover targets tended to be smaller, regional entities. In February 2008, for instance, PGF acquired 57.3% of the shares in the Aptekarz wholesaler, based in Rzeszow, for 26 million zlotys ($8.7 million). In July 2008, Torfarm bought a 100% stake in the distributor Promedic for 700,000 zlotys.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >




Today's issue

Company Spotlight



More Features in Pharmaceutical